Suppr超能文献

在实习医生参与下,整块钬激光剜除术治疗体积非常大的前列腺(>200 cc)的安全性和可行性。

Safety and feasibility of En-bloc holmium laser enucleation for very large prostates (> 200 cc) with trainee involvement.

作者信息

Maluf Feres C, Bhatia Ansh, Khandekar Archan, Lopategui Diana M, Porto Joao G, Chen Ryan R, Daher Jean C, Zarli Mohamadhusni, Marcovich Robert, Shah Hemendra N

机构信息

University of California San Francisco San Francisco CA USA.

Miller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.

出版信息

BJUI Compass. 2024 Dec 20;6(1):e469. doi: 10.1002/bco2.469. eCollection 2025 Jan.

Abstract

OBJECTIVES

To evaluate the safety and feasibility of "en-bloc" Holmium Laser Enucleation of the Prostate (HoLEP) with trainee involvement in patients with prostates larger than 200 cc.

PATIENTS AND METHODS

A retrospective analysis was conducted on patients undergoing HoLEP using the "en-bloc" technique for prostate sizes > 200 cc between July-2017 and December-2023 at an academic teaching hospital. Perioperative data was collected, including patient demographics, clinical parameters, operative details and functional outcomes. Patients who continued to experience incontinence at 1 year were further followed up at 2 years to update their continence status. Sub-group analysis was performed to compare outcomes between patients with preoperative prostate size of 200-300 cc and > 300 cc.

RESULTS

The analysis included 89 patients with a mean age of 73.12 ± 8.10 years. Preoperative prostate weight ranged from 200 to 401 cc with a median of 245 cc, and median PSA was 7.71 ng/ml. Median operative time was 218.5 minutes, and median enucleated prostate volume was 164.2 cc. Median postoperative PSA was 0.4 [0.21-0.78] ng/ml. At 1-year follow-up, mean IPSS was 1 ± 2.4, Qmax was 27.03 ± 11.57 ml/s and PVR was 21.6 ± 28.6 ml. Postoperative complications included blood transfusion (5.6%), acute renal injury (4.5%), urinary tract infection (2.2%), postoperative urinary retention (2.2%) and urethral stricture (5%). Although transient urinary incontinence was noted in 41.6% at 1-3-months, complete continence was achieved in 83.3% and 96.3% at 1 and 2 years postoperatively, respectively. Subgroup analysis showed significant differences in operative time and enucleated weight between prostates 200-300 cc and > 300 cc, but no significant differences in postoperative IPSS, PVR or Qmax at 3-months.

CONCLUSION

"En-bloc" HoLEP is a feasible and safe procedure for prostates larger than 200 cc, demonstrating favourable perioperative and functional outcomes despite the extended operative times and involvement of trainees.

摘要

目的

评估在学员参与下,对前列腺体积大于200cc的患者进行“整块”钬激光前列腺剜除术(HoLEP)的安全性和可行性。

患者与方法

对2017年7月至2023年12月期间在一家学术教学医院接受使用“整块”技术的HoLEP治疗、前列腺体积>200cc的患者进行回顾性分析。收集围手术期数据,包括患者人口统计学资料、临床参数、手术细节和功能结局。对术后1年仍有尿失禁的患者在术后2年进一步随访以更新其尿失禁状态。进行亚组分析以比较术前前列腺体积为200 - 300cc和>300cc的患者之间的结局。

结果

分析纳入89例患者,平均年龄为73.12±8.10岁。术前前列腺重量范围为200至401cc,中位数为245cc,中位前列腺特异性抗原(PSA)为7.71ng/ml。中位手术时间为218.5分钟,中位剜除前列腺体积为164.2cc。术后中位PSA为0.4[0.21 - 0.78]ng/ml。在1年随访时,平均国际前列腺症状评分(IPSS)为1±2.4,最大尿流率(Qmax)为27.03±11.57ml/s,残余尿量(PVR)为21.6±28.6ml。术后并发症包括输血(5.6%)、急性肾损伤(4.5%)、尿路感染(2.2%)、术后尿潴留(2.2%)和尿道狭窄(5%)。尽管在术后1 - 三个月有41.6%的患者出现短暂性尿失禁,但分别在术后1年和2年时,83.3%和96.3%的患者实现了完全控尿。亚组分析显示,前列腺体积200 - 300cc和>300cc的患者在手术时间和剜除重量方面存在显著差异,但在术后3个月时的IPSS、PVR或Qmax方面无显著差异。

结论

对于前列腺体积大于200cc的患者,“整块”HoLEP是一种可行且安全的手术,尽管手术时间延长且有学员参与,但围手术期和功能结局良好。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验